Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    11%
    Check dated 2025-10-06T04:22:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T23:40:40.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.6%
    Check dated 2025-09-14T10:01:19.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-09-07T07:59:47.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, along with multiple study status updates spanning several years. However, several location-related terms have been removed.
    Difference
    28%
    Check dated 2025-08-31T01:08:35.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T20:15:33.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.